Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Nature Reviews. Clinical Oncology
Massimo Di MaioFrancesco Perrone

Abstract

Symptomatic toxicities associated with anticancer treatments, such as nausea and vomiting, are frequently underreported by clinicians, even when data are prospectively collected within clinical trials. Such underreporting can result in an underestimation of the absolute rate of toxicity, which is highly relevant information for patients and their physicians in clinical practice, and for regulatory authorities. Systematic collection of patient-reported outcomes (PROs) has been demonstrated to be a valid, reliable, feasible and precise approach to tabulating symptomatic toxicities and enables symptoms that are missed by clinicians to be detected. In this Perspectives, the barriers and challenges that should be addressed when considering broad integration of PRO toxicity monitoring in oncology clinical trials are discussed, including challenges related to data collection logistics, analytical approaches, and resource utilization. Instruments conceived to enable description of treatment-related adverse effects, from the patient perspective, bring the potential to improve risk-versus-benefit analyses in clinical research, and to provide patients with accurate information, on the basis of previous experiences of their peers.

References

Feb 1, 1991·Journal of Pain and Symptom Management·S A GrossmanS Piantadosi
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erik K FrommeTomasz M Beer
Apr 21, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Morten Aa PetersenMogens Groenvold
Jun 21, 2007·International Journal of Technology Assessment in Health Care·Barry PortnoyEmily DeVoto
Nov 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andy TrottiEthan Basch
Jan 17, 2009·CA: a Cancer Journal for Clinicians·Kathryn RuddyAnn Partridge
Mar 5, 2009·Current Medical Research and Opinion·Donald E StullOlivier Chassany
Nov 19, 2009·Journal of the National Cancer Institute·Ethan BaschDeborah Schrag
Mar 12, 2010·The New England Journal of Medicine·Ethan Basch
Oct 6, 2010·Health Affairs·Albert W WuDonald M Steinwachs
Oct 11, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Thomas M AtkinsonEthan Basch
Dec 14, 2011·Journal of the National Cancer Institute·Ethan BaschM Catherine Pietanza
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschSean Tunis
Jul 23, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jennifer L HayUNKNOWN NCI PRO-CTCAE Study Group
Dec 18, 2013·The American Journal of Gastroenterology·Puja KhannaBrennan Mr Spiegel
Jan 16, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gwenaelle GravisKarim Fizazi
Jul 10, 2014·Journal of the National Cancer Institute·Bryce B ReeveDeborah Watkins Bruner
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo Di MaioFrancesco Perrone
Aug 16, 2015·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Derek KyteMelanie Calvert
Sep 16, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J NaidooJ D Wolchok
Jan 1, 2016·JAMA Oncology·Filippo MontemurroAnna Maria Ballari

❮ Previous
Next ❯

Citations

Jun 2, 2016·Nature Reviews. Clinical Oncology·Ricky A SharmaUNKNOWN NCRI CTRad Academia-Pharma Joint Working Group
Dec 28, 2016·Clinical Pharmacology and Therapeutics·C H van der WoudenUNKNOWN Ubiquitous Pharmacogenomics Consortium
Mar 30, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yih-Lin Chung, Newman N M Pui
Mar 23, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Shuo XiaoTeresa K Woodruff
Apr 19, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eugenie YoungerOlga Husson
Oct 5, 2017·Nature Reviews. Clinical Oncology·Thomas W LeBlanc, Amy P Abernethy
Aug 11, 2018·Journal of Oncology Practice·Nadine J McClearyDeborah Schrag
Mar 7, 2019·Journal of Comparative Effectiveness Research·Francesco SparanoFabio Efficace
Apr 6, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Chiara BaratelliMassimo Di Maio
Jan 29, 2019·Current Topics in Medicinal Chemistry·Junfu ZhangJun Pang
Nov 15, 2018·Journal of Market Access & Health Policy·Szymon JarosławskiMondher Toumi
Mar 30, 2017·Pharmacological Reviews·Annabelle BallestaFrancis A Lévi
Oct 28, 2019·International Journal of Clinical Oncology·Sappaya SuppanuntaroekChikara Ohyama
Nov 18, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jeffrey J KirshnerPhuong Khanh Morrow
Feb 23, 2020·British Journal of Haematology·Rajshekhar Chakraborty, Fabio Efficace
Feb 29, 2020·International Journal of Nanomedicine·Yuzhu HuYongzhong Cheng
Feb 23, 2020·American Journal of Hematology·Rajshekhar Chakraborty, Navneet S Majhail
Sep 19, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Victoria K MarshallRebecca H Lehto
May 18, 2020·Medical Physics·John KangSarah L Kerns
Sep 5, 2020·International Journal of Clinical Practice·Lisa M WintnerBernhard Holzner
Jun 29, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Oxana PaleshPasquale F Innominato
Aug 30, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Olga HussonWinette T A van der Graaf
Jul 19, 2019·Expert Review of Hematology·Pasquale NiscolaFabio Efficace
Sep 5, 2019·NPJ Breast Cancer·Antonio Marra, Giuseppe Curigliano
Jun 1, 2017·International Journal of Hematologic Oncology·Stefano Molica
Aug 24, 2019·Health and Quality of Life Outcomes·Shing M LeeDawn L Hershman
Sep 20, 2019·Drug Discoveries & Therapeutics·Kei KikuchiYasufumi Sawada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Medical Informatics Association : JAMIA
Ethan BaschDeborah Schrag
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Massimo Di MaioFrancesco Perrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ethan BaschDeborah Schrag
© 2022 Meta ULC. All rights reserved